v3.26.1
Financial Instruments and Fair Value Disclosures (Tables)
12 Months Ended
Mar. 31, 2026
Financial Instruments and Fair Value Disclosures:  
Schedule of interest rate swaps, principal terms

The principal terms of our interest rate swaps are as follows:

  ​ ​ ​

  ​ ​ ​

 

 

Transaction

Termination

Fixed

Nominal value

 

Nominal value

 

Interest rate swap

Date

Date

interest rate

March 31, 2026

 

March 31, 2025

 

2023 A&R Debt Facility - ING(1)

January 2023

July 2029

 

2.8525

%  

$

132,000,000

$

148,000,000

(1)Reduces quarterly with final settlement of $80.0 million in July 2029.

Schedule of derivative instruments location on the statement of financial position

The following table summarizes the location on the balance sheet of the financial assets and liabilities that are carried at fair value on a recurring basis, which comprise our financial derivatives all of which are considered Level 2 items in accordance with the fair value hierarchy:

March 31, 2026

March 31, 2025

 

Other non-current assets

Long-term liabilities

Other non-current assets

Long-term liabilities

 

Derivatives not designated as hedging instruments

  ​ ​ ​

Derivative instruments

  ​ ​ ​

Derivative instruments

  ​ ​ ​

Derivative instruments

  ​ ​ ​

Derivative instruments

 

Interest rate swap agreements

$

2,337,425

$

$

3,497,493

$

Schedule of derivative instruments effect within the unaudited interim consolidated statement of operations

The effect of derivative instruments within the consolidated statements of operations for the periods presented is as follows:

Year ended

Derivatives not designated as hedging instruments

  ​ ​ ​

Location of gain/(loss) recognized

 

March 31, 2026

  ​ ​ ​

March 31, 2025

March 31, 2024

 

Interest rate swaps—change in fair value

 

Unrealized (loss)/gain on derivatives

(1,160,068)

(5,786,717)

5,665

Forward freight agreements—realized loss

Realized loss on derivatives

(512,082)

Interest rate swaps—realized gain

 

Realized gain on derivatives

1,759,508

5,824,074

7,493,246

Gain/(loss) on derivatives, net

$

599,440

$

(474,725)

$

7,498,911

Schedule of derivative instruments summary of gains and losses on investment securities

The summary of gains and losses on our investment securities included in other gain/(loss), net on our consolidated statements of operations for the periods presented is as follows:

Year ended

 

March 31, 2026

  ​ ​ ​

March 31, 2025

March 31, 2024

Unrealized gain/(loss) on investment securities

$

1,076,390

$

(1,300,287)

$

1,483,522

Realized gain on investment securities

872,557

Net gain/(loss) on investment securities

$

1,076,390

$

(1,300,287)

$

2,356,079

Schedule of carrying values and estimated fair values of fixed rate debt obligations The following table summarizes the carrying value and estimated fair value of our fixed rate debt obligations as of:

March 31, 2026

March 31, 2025

  ​ ​ ​

Carrying Value

  ​ ​ ​

Fair Value

  ​ ​ ​

Carrying Value

  ​ ​ ​

Fair Value

Corsair Japanese Financing

$

24,645,833

$

24,354,660

$

27,895,834

$

27,449,194

Cresques Japanese Financing

22,071,744

23,176,904

23,840,367

25,079,649

Cratis Japanese Financing

33,340,000

32,066,599

37,420,000

35,683,595

Copernicus Japanese Financing

33,340,000

32,066,599

37,420,000

35,683,595

Chaparral Japanese Financing

54,594,492

54,386,863

57,316,129

56,960,711

Caravelle Japanese Financing

35,300,000

33,893,259

39,200,000

37,313,039

Cougar Japanese Financing

36,500,000

37,996,095

40,100,000

41,274,707

Captain Markos Dual-Fuel Japanese Financing

48,230,000

51,115,820

50,960,000

54,060,280

BALCAP Facility

49,891,595

49,119,651

58,266,112

56,498,815